MAPK/ERK1/2 pathways play critical roles in cell growth, apoptosis and metastasis [36], and several studies reported that MMP activities could be affected by the level of p-ERK1/2 in ESCC [19, 37]. This evidence concerns the gene MAPK3 and esophageal squamous cell carcinoma.